£95.00

Retatrutide: Triple-action innovation in weight management

A triple hormone therapy currently showing promising results in clinical studies.

  • Early trial data shows greater weight loss than both Semaglutide and Tirzepatide

  • May improve overall metabolic health beyond weight loss

  • Triple hormone activation for superior appetite regulation

  • Weekly injection, doctor-prescribed

Category:

Description

Retatrutide is a triple agonist that activates GLP-1, GIP, and glucagon receptors.
This unique triple-action approach may provide unprecedented results in weight loss and metabolic improvement compared to current single or dual therapies.

Benefits of Semaglutide

  • Triple hormone activation for superior appetite regulation
  • Early trial data shows greater weight loss than both Semaglutide and Tirzepatide
  • May improve overall metabolic health beyond weight loss
  • Weekly injection, doctor-prescribed

Purity: ≥ 99%
Form: Lyophilized Powder
Molecular Formula: C194H296N52O60
Molecular Weight: ≈ 4808 g/mol
Storage: Keep refrigerated at 2–8 °C (35–46 °F). Protect from light. Do not freeze.
Handling: For laboratory research use only – not for human or veterinary use.
Reconstitution: Reconstitute using sterile bacteriostatic water under aseptic conditions. Gently swirl; do not shake.
Stability: Use within 30 days of reconstitution when stored under refrigeration.
Safety: Avoid contact with skin, eyes, or mucous membranes. Keep out of reach of children.
Disclaimer: This product is intended for in vitro research purposes only. It is not for human consumption, diagnostic procedures, or therapeutic applications.

Reviews

There are no reviews yet.

Be the first to review “Retatrutide 10mg”

Your email address will not be published. Required fields are marked *